TY - JOUR T1 - Feasibility and acceptability of a patient-reported outcome intervention in chronic heart failure JF - BMJ Supportive & Palliative Care JO - BMJ Support Palliat Care DO - 10.1136/bmjspcare-2017-001355 SP - bmjspcare-2017-001355 AU - Pauline M Kane AU - Barbara A Daveson AU - Karen Ryan AU - Clare I Ellis-Smith AU - Niall G Mahon AU - Brendan McAdam AU - Regina McQuilllan AU - Cecelia Tracey AU - Christine Howley AU - Geraldine O'Gara AU - Caroline Raleigh AU - Irene J Higginson AU - Jonathan Koffman AU - Fliss E M Murtagh A2 - , Y1 - 2017/09/01 UR - http://spcare.bmj.com/content/early/2017/09/01/bmjspcare-2017-001355.abstract N2 - Patients with chronic heart failure (CHF) have symptoms and concerns which are inadequately addressed. Patient-reported outcome measures (PROMs) can potentially improve the identification and management of advanced symptoms and palliative concerns. However, these have not been used in CHF.Objectives To examine the feasibility and acceptability of using a PROM—the Integrated Palliative care Outcome Scale (IPOS)—together with heart failure nurse education and training to improve the identification and management of symptoms and concerns among patients with CHF.Methods A parallel, mixed methods design with an embedded qualitative component was used to examine the feasibility of recruitment, retention, intervention adherence/compliance and follow-up assessment completion (symptom burden, quality of life, psychological well-being). Patient and nurse qualitative semistructured interviews explored intervention and study design feasibility and its acceptability.Results Conversion to consent was 46.9% (372 screened, 81 approached, 38 recruited). 66% of patient participants completed the IPOS; 6% of IPOS questionnaire items were missing (non-response). Over two-thirds (65.6%) of these missing items related to three patients. No item was consistently missing; appetite was the most frequent missing item (1.4%). 92% of participants who completed the IPOS completed all follow-up assessments (1–2 days, 1–2 weeks and 4–6 weeks post-IPOS completion) with no missing data. The a priori feasibility objectives were met. Patients and nurses reported the intervention and study design feasible and acceptable.Conclusions A palliative-specific PROM-based intervention is feasible and acceptable to both patients with CHF and nurses in nurse-led disease management clinics for the purposes of both clinical care and research. ER -